Definition of Tremelimumab. Meaning of Tremelimumab. Synonyms of Tremelimumab

Here you will find one or more explanations in English for the word Tremelimumab. Also in the bottom left of the page several parts of wikipedia pages related to the word Tremelimumab and, of course, Tremelimumab synonyms and on the right images related to the word Tremelimumab.

Definition of Tremelimumab

No result for Tremelimumab. Showing similar results...

Meaning of Tremelimumab from wikipedia

- Tremelimumab, sold under the brand name Imjudo, is a fully human monoclonal antibody used for the treatment of hepatocellular carcinoma (a type of liver...
- receive durvalumab as a single agent, durvalumab in combination with tremelimumab, or placebo. In March 2025, the FDA approved durvalumab with gemcitabine...
- AstraZeneca employees as of 2024. In April 2015, AstraZeneca's drug tremelimumab was approved as an orphan drug for the treatment of mesothelioma in the...
- Administration. Retrieved 2023-05-22. FDA : Drugs (May 31, 2022) "FDA approves tremelimumab in combination with durvalumab for unresectable hepatocellular carcinoma"...
- inhibitors include anti-CTLA-4 monoclonal antibodies (ipilimumab and tremelimumab), toll-like receptor (TLR) agonists, CD40 agonists, anti-PD-1 (pembrolizumab...
- Sacituzumab govitecan L01FX18 Amivantamab L01FX19 Sabatolimab L01FX20 Tremelimumab L01FX21 Naxitamab L01FX22 Loncastuximab tesirine L01FX23 Tisotumab vedotin...
- Ulocuplumab Varlilumab Immune activation: Ipilimumab Durvalumab Nivolumab Tremelimumab Urelumab Other: Bertilimumab Ontamalimab Zanolimumab Combination: Nivolumab/relatlimab...
- (USAN) trelnarizine (INN) treloxinate (INN) Trelstar tremacamra (INN) tremelimumab (USAN) Tremfya Tremin trenbolone (INN) Trendar trengestone (INN) trenizine...
- with Pexa-Vec and AstraZeneca's checkpoint inhibitors durvalumab and tremelimumab. INTERNET, CENTUM. "SOLVE® > TECHNOLOGY > Sillajen". www.sillajen.com...
- of cancer. Major phase III trials included: durvalumab (anti-PD-L1) tremelimumab (anti-CTLA-4) moxetumomab pasudotox (anti-CD22) benralizumab (anti-IL-5R)...